Bio-Path Holdings Inc
Search For a Symbol
Bio-Path Holdings Inc Stock, NASDAQ:BPTH
4710 Bellaire Boulevard, Suite 210, Bellaire, Texas 77401
United States of America
Number of Employees: 10
Bio-Path Holdings, Inc. is a biotechnology company, which engages in the development of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline includes Prexigebersen, BP1002, and BP1003. The company was founded by Peter H. Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.